Featured Research

from universities, journals, and other organizations

Drug-Resistant Bacteria May Find New Foe In Novel Drug Design Approach

Date:
August 27, 2004
Source:
Harvard Medical School
Summary:
At the 228th national meeting of the American Chemical Society held this week in Philadelphia, researchers from Harvard Medical School report that they have found a way to produce novel aminocoumarins – antibiotics that can help in the fight against drug-resistant bacteria.

PHILADELPHIA, PA (August 25, 2004) -- At the 228th national meeting of the American Chemical Society held this week in Philadelphia, researchers from Harvard Medical School report that they have found a way to produce novel aminocoumarins – antibiotics that can help in the fight against drug-resistant bacteria.

The development of bacterial resistance to antibiotics is a major public health concern. Currently, doctors have precious few weapons to fight strains such as methicillin-resistant Staphylococcus aureus (MRSA). Though some of these “super bugs” are sensitive to aminocoumarins, there’s a catch. Low solubility, poor absorption and distribution, and the inability to penetrate the bacterial cell wall, make these compounds less than ideal antibiotics.

Now, Christopher T. Walsh, the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, and colleagues report a method that can be used to generate potentially hundreds of aminocoumarin variants. “This approach allows the controlled variation of all parts of the aminocoumarin scaffold in the search to create antibiotics with tailored and improved properties,” said Walsh.

In an ironic twist, the method developed by the researchers exploits bacterial enzymes. Caren Freel Meyers, a research fellow in Walsh’s lab, has used an alphabet soup of proteins from Streptomyces to make an enzymatic production line that adds, stepwise, different chemical moieties to the backbone of coumermycin A1, a member of the aminocoumarin family of antibiotics.

Starting with this coumermycin scaffold, Freel Meyers used the enzyme CouL to add one or two amino groups, then CouM to add a sugar component called L-noviose. The enzyme CouP was found to add methyl groups to the CouM products, and NovN was used to add one or two carbamoyl moieties to methylated CouP product variants. By playing mix-and-match with enzymes and CouL substrates that make up the coumermycin A1 backbone, multiple designs can be rolled off the production line. In a proof of principle experiment, Freel Meyers generated a library of nine coumermycin variants. Three of these compounds have been produced in sufficient quantity for detailed analysis, and they are currently undergoing biological evaluation.

Aminocoumarins are inhibitors of bacterial type II topoisomerases, enzymes that untwist and unknot DNA. Without these topoisomerases bacteria cannot replicate. For this reason, fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin, which are potent inhibitors of type II topoisomerases, have found widespread use. However, the emergence of resistant bacterial strains has renewed interest in the aminocoumarin novobiocin, which is one of the few drugs available that is effective against MRSA.

The sugar moieties attached to the coumermycin backbone are thought to bind to and inactivate the essential bacterial topoisomerase DNA gyrase. By modifying the noviose substituents Freel Meyers and colleagues hope to develop more effective gyrase inhibitors. By modifying other components of the backbone the researchers hope to turn these inhibitors into potent antibiotics, ones that are more soluble, have better pharmacokinetics, and more readily penetrate their bacterial targets.


Story Source:

The above story is based on materials provided by Harvard Medical School. Note: Materials may be edited for content and length.


Cite This Page:

Harvard Medical School. "Drug-Resistant Bacteria May Find New Foe In Novel Drug Design Approach." ScienceDaily. ScienceDaily, 27 August 2004. <www.sciencedaily.com/releases/2004/08/040826085711.htm>.
Harvard Medical School. (2004, August 27). Drug-Resistant Bacteria May Find New Foe In Novel Drug Design Approach. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2004/08/040826085711.htm
Harvard Medical School. "Drug-Resistant Bacteria May Find New Foe In Novel Drug Design Approach." ScienceDaily. www.sciencedaily.com/releases/2004/08/040826085711.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins